309 related articles for article (PubMed ID: 29281924)
1. One-pot three-component synthesis of novel spirooxindoles with potential cytotoxic activity against triple-negative breast cancer MDA-MB-231 cells.
Eldehna WM; El-Naggar DH; Hamed AR; Ibrahim HS; Ghabbour HA; Abdel-Aziz HA
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):309-318. PubMed ID: 29281924
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, Crystal Study, and Anti-Proliferative Activity of Some 2-Benzimidazolylthioacetophenones towards Triple-Negative Breast Cancer MDA-MB-468 Cells as Apoptosis-Inducing Agents.
Abdel-Aziz HA; Eldehna WM; Ghabbour H; Al-Ansary GH; Assaf AM; Al-Dhfyan A
Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27483243
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A
Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326
[TBL] [Abstract][Full Text] [Related]
4. Novel Thiazolidinone/Thiazolo[3,2-
El-Naggar M; Eldehna WM; Almahli H; Elgez A; Fares M; Elaasser MM; Abdel-Aziz HA
Molecules; 2018 Jun; 23(6):. PubMed ID: 29895744
[TBL] [Abstract][Full Text] [Related]
5. Novel racemosin B derivatives as new therapeutic agents for aggressive breast cancer.
Xiao X; Xu M; Yang C; Yao Y; Liang LN; Ed Chung P; Long Q; Zacksenhaus E; He Z; Liu S; Ben-David Y
Bioorg Med Chem; 2018 Dec; 26(23-24):6096-6104. PubMed ID: 30471828
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro anti-proliferative activity of some novel isatins conjugated with quinazoline/phthalazine hydrazines against triple-negative breast cancer MDA-MB-231 cells as apoptosis-inducing agents.
Eldehna WM; Almahli H; Al-Ansary GH; Ghabbour HA; Aly MH; Ismael OE; Al-Dhfyan A; Abdel-Aziz HA
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):600-613. PubMed ID: 28173708
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Biological Evaluation and In Silico Studies of Certain Oxindole-Indole Conjugates as Anticancer CDK Inhibitors.
Al-Warhi T; El Kerdawy AM; Aljaeed N; Ismael OE; Ayyad RR; Eldehna WM; Abdel-Aziz HA; Al-Ansary GH
Molecules; 2020 Apr; 25(9):. PubMed ID: 32349307
[TBL] [Abstract][Full Text] [Related]
8. In vitro targeting of colon cancer cells using spiropyrazoline oxindoles.
Nunes RC; Ribeiro CJA; Monteiro Â; Rodrigues CMP; Amaral JD; Santos MMM
Eur J Med Chem; 2017 Oct; 139():168-179. PubMed ID: 28800455
[TBL] [Abstract][Full Text] [Related]
9. Sulfamic acid promoted one-pot three-component synthesis and cytotoxic evaluation of spirooxindoles.
Kamal A; Babu KS; Vishnu Vardhan MV; Hussaini SM; Mahesh R; Shaik SP; Alarifi A
Bioorg Med Chem Lett; 2015; 25(10):2199-202. PubMed ID: 25870131
[TBL] [Abstract][Full Text] [Related]
10. New (E)-1-alkyl-1H-benzo[d]imidazol-2-yl)methylene)indolin-2-ones: Synthesis, in vitro cytotoxicity evaluation and apoptosis inducing studies.
Sharma P; Thummuri D; Reddy TS; Senwar KR; Naidu VGM; Srinivasulu G; Bharghava SK; Shankaraiah N
Eur J Med Chem; 2016 Oct; 122():584-600. PubMed ID: 27448916
[TBL] [Abstract][Full Text] [Related]
11. Design, combinatorial synthesis and biological evaluations of novel 3-amino-1'-((1-aryl-1H-1,2,3-triazol-5-yl)methyl)-2'-oxospiro[benzo[a] pyrano[2,3-c]phenazine-1,3'-indoline]-2-carbonitrile antitumor hybrid molecules.
Lu Y; Wang L; Wang X; Xi T; Liao J; Wang Z; Jiang F
Eur J Med Chem; 2017 Jul; 135():125-141. PubMed ID: 28441581
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of spiro[cyclopropane-1,3'-indolin]-2'-ones as potential anticancer agents.
Reddy CN; Nayak VL; Mani GS; Kapure JS; Adiyala PR; Maurya RA; Kamal A
Bioorg Med Chem Lett; 2015 Oct; 25(20):4580-6. PubMed ID: 26330077
[TBL] [Abstract][Full Text] [Related]
13. One-pot mild and efficient synthesis of [1,3]thiazino[3,2-a]indol-4-ones and their anti-proliferative activity.
Rhodes S; Short S; Sharma S; Kaur R; Jha M
Org Biomol Chem; 2019 Apr; 17(16):3914-3920. PubMed ID: 30942251
[TBL] [Abstract][Full Text] [Related]
14. H2O-mediated isatin spiro-epoxide ring opening with NaCN: Synthesis of novel 3-tetrazolylmethyl-3-hydroxy-oxindole hybrids and their anticancer evaluation.
Sharma P; Senwar KR; Jeengar MK; Reddy TS; Naidu VG; Kamal A; Shankaraiah N
Eur J Med Chem; 2015 Nov; 104():11-24. PubMed ID: 26413726
[TBL] [Abstract][Full Text] [Related]
15. Synthetic Spirocyclohexadienones as New Anti-Migratory Compounds in Triple- Negative Breast Cancer Cell Migration.
Altei WF; Pachane BC; Martins LJ; Gomes RC; Santos RN; Fernandes DC; Selistre-de-Araújo HS; Coelho F; Andricopulo AD
Anticancer Agents Med Chem; 2021; 21(14):1901-1910. PubMed ID: 33292143
[TBL] [Abstract][Full Text] [Related]
16. Spirooxindole-derived morpholine-fused-1,2,3-triazoles: Design, synthesis, cytotoxicity and apoptosis inducing studies.
Senwar KR; Sharma P; Reddy TS; Jeengar MK; Nayak VL; Naidu VG; Kamal A; Shankaraiah N
Eur J Med Chem; 2015 Sep; 102():413-24. PubMed ID: 26301558
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and structure-activity relationship studies of a focused library of pyrimidine moiety with anti-proliferative and anti-metastasis activities in triple negative breast cancer.
Yao D; Zhou Y; Zhu L; Ouyang L; Zhang J; Jiang Y; Zhao Y; Sun D; Yang S; Yu Y; Wang J
Eur J Med Chem; 2017 Nov; 140():155-171. PubMed ID: 28923383
[TBL] [Abstract][Full Text] [Related]
18. New bis(hydroxymethyl) alkanoate curcuminoid derivatives exhibit activity against triple-negative breast cancer in vitro and in vivo.
Hsieh MT; Chang LC; Hung HY; Lin HY; Shih MH; Tsai CH; Kuo SC; Lee KH
Eur J Med Chem; 2017 May; 131():141-151. PubMed ID: 28319780
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents.
Luo Y; Wu W; Zha D; Zhou W; Wang C; Huang J; Chen S; Yu L; Li Y; Huang Q; Zhang J; Zhang C
Bioorg Med Chem Lett; 2021 Sep; 47():128230. PubMed ID: 34186178
[TBL] [Abstract][Full Text] [Related]
20. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.
Ünal TD; Hamurcu Z; Delibaşı N; Çınar V; Güler A; Gökçe S; Nurdinov N; Ozpolat B
Anticancer Agents Med Chem; 2021; 21(3):355-364. PubMed ID: 32767958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
